Vertex Pharmaceuticals Incorporated (VRTX)
After hours:
| Previous close | 281.79 |
| Open | 280.17 |
| Bid | 285.55 x 900 |
| Ask | 288.20 x 800 |
| Day's range | 279.46 - 287.86 |
| 52-week range | 176.36 - 293.17 |
| Volume | |
| Avg. volume | 1,769,017 |
| Market cap | 73.484B |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | 29.71 |
| EPS (TTM) | 9.67 |
| Earnings date | 27 Jul 2022 - 01 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 293.51 |
- Motley Fool
If You Invested $25,000 in Vertex Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today
If you hold on to a promising growth stock for five years, you should expect to accumulate some decent gains over that time. Investing in just the S&P 500 would have resulted in a nearly 60% increase in value -- and that's even after factoring in this year's bearish market. Five years ago, Vertex Pharmaceuticals (NASDAQ: VRTX) was coming off a year when its revenue soared by 65% to $1.7 billion.
- Motley Fool
3 Great Stocks to Buy If a Recession Is On the Way
Is a recession coming? Ark Invest CEO Cathie Wood thinks that one has already arrived. Economists surveyed by The Wall Street Journal put the odds of a recession over the next 12 months at 44%. Federal Reserve chairman Jerome Powell recently said that a recession is "a possibility," although the Fed is trying to avoid causing one with its interest rate hikes.
- Zacks
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $280.35, marking a +1.51% move from the previous day.
